- Home
- CRBU vs TSI Comparison
CRBU vs TSI Comparison
Compare CRBU & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- TSI
- Stock Information
- Founded
- CRBU 2011
- TSI 1987
- Country
- CRBU United States
- TSI United States
- Employees
- CRBU N/A
- TSI N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- TSI Investment Managers
- Sector
- CRBU Health Care
- TSI Finance
- Exchange
- CRBU Nasdaq
- TSI Nasdaq
- Market Cap
- CRBU 236.3M
- TSI 241.8M
- IPO Year
- CRBU 2021
- TSI N/A
- Fundamental
- Price
- CRBU $1.79
- TSI $5.01
- Analyst Decision
- CRBU Strong Buy
- TSI
- Analyst Count
- CRBU 4
- TSI 0
- Target Price
- CRBU $12.00
- TSI N/A
- AVG Volume (30 Days)
- CRBU 1.5M
- TSI 106.8K
- Earning Date
- CRBU 11-06-2024
- TSI 01-01-0001
- Dividend Yield
- CRBU N/A
- TSI 7.46%
- EPS Growth
- CRBU N/A
- TSI N/A
- EPS
- CRBU N/A
- TSI N/A
- Revenue
- CRBU $11,475,000.00
- TSI N/A
- Revenue This Year
- CRBU N/A
- TSI N/A
- Revenue Next Year
- CRBU N/A
- TSI N/A
- P/E Ratio
- CRBU N/A
- TSI N/A
- Revenue Growth
- CRBU N/A
- TSI N/A
- 52 Week Low
- CRBU $1.50
- TSI $4.48
- 52 Week High
- CRBU $8.33
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- CRBU 37.96
- TSI 50.11
- Support Level
- CRBU $1.72
- TSI $4.98
- Resistance Level
- CRBU $1.97
- TSI $5.07
- Average True Range (ATR)
- CRBU 0.14
- TSI 0.03
- MACD
- CRBU -0.03
- TSI -0.00
- Stochastic Oscillator
- CRBU 9.12
- TSI 33.33
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment, and others.